Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Idera Pharmaceuticals Inc (NASDAQ:IDRA)

2.76
Delayed Data
As of Sep 23
 -0.03 / -1.08%
Today’s Change
1.19
Today|||52-Week Range
4.42
-10.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues20.0K190.0K294.0K301.0K
 
 
 
 
 
Depreciation And Amortization133.0K159.0K157.0K160.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses11.4M12.1M13.1M13.7M
 
 
 
 
 
Research And Development7.5M8.6M9.3M10.1M
 
 
 
 
 
Total Operating Expenses11.5M12.3M13.2M13.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.5M-12.1M-12.9M-13.6M
 
 
 
 
 
Interest Expense On Debt27.0K24.0K23.0K21.0K
 
 
 
 
 
Other Expenses3.0K-1.0K-2.0K31.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.4M-12.0M-12.8M-13.5M
 
 
 
 
 
Net Income-11.4M-12.0M-12.8M-13.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS118.2M118.9M121.3M121.3M
 
 
 
 
 
Shares To Calculate EPS Diluted118.2M118.9M121.3M121.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.10-$0.11-$0.11
 
 
 
 
 
EPS Diluted-$0.10-$0.10-$0.11-$0.11